Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-edited cell therapy, eliminated vaso-occlusive crises in 97% of participants with severe sickle cell disease. The therapy led to substantial ...
Hoosiers from across the state will gather at the Indiana State Capitol on Monday, Feb. 2, to call attention to the urgent ...
A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results